Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report.

Tsuyoshi OkuraYohei FujiokaRisa NakamuraYuichi ItoSonoko KitaoMari AnnoKazuhisa MatsumotoKyoko ShojiHiroko OkuraKazuhiko MatsuzawaShoichiro IzawaEtsuko UetaMasahiko KatoTakeshi ImamuraShin-Ichi TaniguchiKazuhiro Yamamoto

Published in: Diabetology & metabolic syndrome (2022)

Although the number of patients was very small, these results suggested that DPP4i treatment might improve insulin resistance without changing insulin secretion.

Keyphrases

insulin resistance
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
type diabetes
metabolic syndrome
adipose tissue
prognostic factors
high fat diet
skeletal muscle
polycystic ovary syndrome
patient reported outcomes
combination therapy